This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Cdrd Ventures Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Eric Roy Simonson: Innovator in Somatostatin Receptor Antagonist Compounds
Introduction
Eric Roy Simonson is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmacology, particularly through his innovative work on somatostatin receptor antagonist compounds. His research focuses on developing compounds that may aid in the prevention or treatment of hypoglycemia.
Latest Patents
Eric holds one patent titled "Somatostatin receptor antagonist compounds and methods of using the same." This invention is directed to somatostatin receptor antagonist compounds characterized by a specific structure, as outlined in Formula I. The patent also includes compositions comprising these compounds and methods for their application.
Career Highlights
Eric Roy Simonson is associated with CDRD Ventures Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues for managing blood sugar levels.
Collaborations
Some of Eric's coworkers include Stephen Paul Arns and James Brian Jaquith. Their collaborative efforts contribute to the innovative environment at CDRD Ventures Inc.
Conclusion
Eric Roy Simonson's work in developing somatostatin receptor antagonist compounds showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of hypoglycemia and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile